Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Kyowa Kirin Co Ltd

4151.T ✓ COMPLIANT ☆ Track — members

Tokyo Exchange · Healthcare · Pharmaceuticals ·

Japan Mid Cap Analyst: HOLD

Last Close

$15.38

▼ -1.09%

Market Cap $8.11B · Vol 2.17M

Key Metrics

P/E Ratio

15.47

FWD: 13.69

Market Cap

$8.11B

Mid Cap

Div Yield

2.79%

Semi-annual dividend

EPS Growth

+24.43%

YoY

RSI (14)

40.18

Momentum

Beta

0.73

vs Market

52W High

$18.64

17.56% below

52W Low

$13.50

14.93% above

Volume

2.17M

Avg 1.37M

P/B

1.48

Price-to-book

ROE

7.70%

Return on equity

Free Float

44.06%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Kyowa Kirin Co Ltd (4151.T) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 4151.T pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-9.76%

-1.98%

+4.52%

+7.73%

YTD

-4.89%

-8.91%

-14.25%

-37.97%

Financials & Valuation

TTM · Annual

Total Revenue	$3.17B
Net Income	$427.95M
Revenue Growth (YoY)	+15.27%
Gross Margin	74.25%
Operating Margin	19.80%
Net Profit Margin	13.49%
ROE	7.70%
ROA · ROIC	8.02% · 7.73%

P/E Ratio	15.47
Forward P/E (FY1)	13.69
PEG Ratio	1.49
P/S	2.66
P/B	1.48
P/FCF	100.97
EPS Growth	+24.43%
Outstanding Shares	525.63M

Technical Indicators

50-Day SMA	$16.61
200-Day SMA	$16.12
RSI (14)	40.18
Beta	0.73
52-Week High	$18.64
52-Week Low	$13.50

Volume Today	2.17M
Avg Daily Volume (30D)	1.37M
Relative Volume	1.58x
Volatility (10D)	61.11
Volatility (30D)	41.41
Free Float	44.06%

Analyst Consensus

HOLD

Current Price $15.38

Mean Target $15.16

52W Low$13.50 52W High$18.64

Current

Target

$13.50 $18.64

Current Analyst target

-1.45% downside risk · 12 analysts

Identifiers

ExchangeTokyo Exchange

FIGIBBG001S6B983

ISINJP3256000005

CountryJapan

Sub-IndustryProprietary & Advanced Pharmaceuticals

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MRK Merck & Co Inc -1.32% MRK.DE Merck KGaA -1.45% HALO Halozyme Therapeutics Inc -0.51% 326030.KS SK Biopharmaceuticals Co Ltd +0.23% 000100.KS Yuhan Corp +0.00%

Company Profile

Kyowa Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of medical drugs. The Company operates in Pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has drug discovery technologies in antibody therapeutics and hematopoietic stem cell gene therapy. Its development pipeline includes AMG531 for aplastic anemia untreated with immunosuppressive therapy, KHK4083/AMG 451 for moderate to severe atopic dermatitis, KHK4083/AMG 451 for moderate to severe asthma, and KK2845 for acute myeloid leukemia and others. In addition, through its subsidiaries, the Company develops, manufactures, markets, and contracts out biosimilar pharmaceuticals, and engages in wholesale and retail sales and insurance agency business. The Company operates in Japan and overseas.